Literature DB >> 18438514

A study of typhoid fever in five Asian countries: disease burden and implications for controls.

R Leon Ochiai1, Camilo J Acosta, M Carolina Danovaro-Holliday, Dong Baiqing, Sujit K Bhattacharya, Magdarina D Agtini, Zulfiqar A Bhutta, Do Gia Canh, Mohammad Ali, Seonghye Shin, John Wain, Anne-Laure Page, M John Albert, Jeremy Farrar, Remon Abu-Elyazeed, Tikki Pang, Claudia M Galindo, Lorenz von Seidlein, John D Clemens.   

Abstract

OBJECTIVE: To inform policy-makers about introduction of preventive interventions against typhoid, including vaccination.
METHODS: A population-based prospective surveillance design was used. Study sites where typhoid was considered a problem by local authorities were established in China, India, Indonesia, Pakistan and Viet Nam. Standardized clinical, laboratory, and surveillance methods were used to investigate cases of fever of >or= 3 days' duration for a one-year period. A total of 441,435 persons were under surveillance, 159,856 of whom were aged 5-15 years.
FINDINGS: A total of 21,874 episodes of fever were detected. Salmonella typhi was isolated from 475 (2%) blood cultures, 57% (273/475) of which were from 5-15 year-olds. The annual typhoid incidence (per 100,000 person years) among this age group varied from 24.2 and 29.3 in sites in Viet Nam and China, respectively, to 180.3 in the site in Indonesia; and to 412.9 and 493.5 in sites in Pakistan and India, respectively. Altogether, 23% (96/413) of isolates were multidrug resistant (chloramphenicol, ampicillin and trimethoprim-sulfamethoxazole).
CONCLUSION: The incidence of typhoid varied substantially between sites, being high in India and Pakistan, intermediate in Indonesia, and low in China and Viet Nam. These findings highlight the considerable, but geographically heterogeneous, burden of typhoid fever in endemic areas of Asia, and underscore the importance of evidence on disease burden in making policy decisions about interventions to control this disease.

Entities:  

Mesh:

Year:  2008        PMID: 18438514      PMCID: PMC2647431          DOI: 10.2471/blt.06.039818

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  28 in total

1.  The global burden of typhoid fever.

Authors:  John A Crump; Stephen P Luby; Eric D Mintz
Journal:  Bull World Health Organ       Date:  2004-05       Impact factor: 9.408

2.  Factors associated with reported diarrhoea episodes and treatment-seeking in an urban slum of Kolkata, India.

Authors:  Dipika Sur; Byomkesh Manna; Alok K Deb; Jacqueline L Deen; M Carolina Danovaro-Holliday; Lorenz von Seidlein; John D Clemens; Sujit K Bhattacharya
Journal:  J Health Popul Nutr       Date:  2004-06       Impact factor: 2.000

3.  Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.

Authors:  H H Yang; C G Wu; G Z Xie; Q W Gu; B R Wang; L Y Wang; H F Wang; Z S Ding; Y Yang; W S Tan; W Y Wang; X C Wang; M Qin; J H Wang; H A Tang; X M Jiang; Y H Li; M L Wang; S L Zhang; G L Li
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

4.  Bone marrow aspirate culture superior to streptokinase clot culture and 8 ml 1:10 blood-to-broth ratio blood culture for diagnosis of typhoid fever.

Authors:  S L Hoffman; D C Edman; N H Punjabi; M Lesmana; A Cholid; S Sundah; J Harahap
Journal:  Am J Trop Med Hyg       Date:  1986-07       Impact factor: 2.345

5.  Comparative yield of Salmonella typhi from blood and bone marrow cultures in patients with fever of unknown origin.

Authors:  B J Farooqui; M Khurshid; M K Ashfaq; M A Khan
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

6.  Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

Authors:  I L Acharya; C U Lowe; R Thapa; V L Gurubacharya; M B Shrestha; M Cadoz; D Schulz; J Armand; D A Bryla; B Trollfors
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

Review 7.  The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.

Authors:  Christopher M Parry
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-07       Impact factor: 2.184

8.  Controlled field trial of a high-dose oral killed typhoid vaccine in India.

Authors:  C S Chuttani; K Prakash; P Gupta; V Grover; A Kumar
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

9.  Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever.

Authors:  R H Gilman; M Terminel; M M Levine; P Hernandez-Mendoza; R B Hornick
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

10.  The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Authors:  F Y Lin; V A Ho; H B Khiem; D D Trach; P V Bay; T C Thanh; Z Kossaczka; D A Bryla; J Shiloach; J B Robbins; R Schneerson; S C Szu
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 176.079

View more
  199 in total

1.  Rift Valley Fever: scientific pathways toward public health prevention and response.

Authors:  Robert F Breiman; Bruno Minjauw; S K Sharif; Peter Ithondeka; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Factors associated with occurrence of salmonellosis among children living in Mukuru slum, an urban informal settlement in Kenya.

Authors:  Cecilia Mbae; Moses Mwangi; Naomi Gitau; Tabitha Irungu; Fidelis Muendo; Zilla Wakio; Ruth Wambui; Susan Kavai; Robert Onsare; Celestine Wairimu; Ronald Ngetich; Frida Njeru; Sandra Van Puyvelde; John Clemens; Gordon Dougan; Samuel Kariuki
Journal:  BMC Infect Dis       Date:  2020-06-17       Impact factor: 3.090

Review 3.  Signature tagged mutagenesis in the functional genetic analysis of gastrointestinal pathogens.

Authors:  Joanne Cummins; Cormac G M Gahan
Journal:  Gut Microbes       Date:  2012-03-01

4.  Phase I clinical trial of O-acetylated pectin conjugate, a plant polysaccharide based typhoid vaccine.

Authors:  Shousun C Szu; Kimi F-Y Lin; Steven Hunt; Chiayung Chu; Nguyen Duc Thinh
Journal:  Vaccine       Date:  2014-03-21       Impact factor: 3.641

5.  Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan.

Authors:  Aatekah Owais; Shazia Sultana; Umber Zaman; Arjumand Rizvi; Anita K M Zaidi
Journal:  Pediatr Infect Dis J       Date:  2010-11       Impact factor: 2.129

6.  The expanding spectrum of disease due to salmonella: an international perspective.

Authors:  Laila Woc-Colburn; David A Bobak
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

Review 7.  Antimicrobial resistance and management of invasive Salmonella disease.

Authors:  Samuel Kariuki; Melita A Gordon; Nicholas Feasey; Christopher M Parry
Journal:  Vaccine       Date:  2015-04-23       Impact factor: 3.641

Review 8.  Global trends in typhoid and paratyphoid Fever.

Authors:  John A Crump; Eric D Mintz
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

9.  A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.

Authors:  Shousun C Szu; Steven Hunt; Guilin Xie; John B Robbins; Rachel Schneerson; Rajesh K Gupta; Zhigang Zhao; Xiaomei Tan
Journal:  Vaccine       Date:  2013-02-17       Impact factor: 3.641

10.  A Study on Longevity of Immune Response after Vaccination with Salmonella Typhi Vi Conjugate Vaccine (Pedatyph™) in Children.

Authors:  Balaji Chinnasami; Kanimozhi Sadasivam; Aravindhan Vivekanandhan; Prema Arunachalam; Sekar Pasupathy
Journal:  J Clin Diagn Res       Date:  2015-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.